Microbial biofilm formation: a need to act
暂无分享,去创建一个
S. Kjelleberg | S. Normark | B. Uhlin | U. Römling | S. Normark | U. Römling | S. Kjelleberg | L. Nyman | B. E. Uhlin | B. Åkerlund | B. Åkerlund | L. Nyman | Staffan Normark
[1] M. Chapman,et al. Mechanisms of Protein Oligomerization: Inhibitor of Functional Amyloids Templates α-Synuclein Fibrillation , 2012, Journal of the American Chemical Society.
[2] P. Humphrey,et al. Detection of Intracellular Bacterial Communities in Human Urinary Tract Infection , 2007, PLoS medicine.
[3] S. Molin,et al. Phenotypes of Non-Attached Pseudomonas aeruginosa Aggregates Resemble Surface Attached Biofilm , 2011, PloS one.
[4] T. D. Yuzvinsky,et al. Electrical transport along bacterial nanowires from Shewanella oneidensis MR-1 , 2010, Proceedings of the National Academy of Sciences.
[5] C. Kirschner,et al. The role of intermolecular interactions: studies on model systems for bacterial biofilms. , 1999, International journal of biological macromolecules.
[6] K. Nealson,et al. Cellular Control of the Synthesis and Activity of the Bacterial Luminescent System , 1970, Journal of bacteriology.
[7] Qian Zhang,et al. Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins , 2004, Nature Biotechnology.
[8] S. Rice,et al. Cephalosporin-3'-diazeniumdiolates: targeted NO-donor prodrugs for dispersing bacterial biofilms. , 2012, Angewandte Chemie.
[9] J. M. Dow,et al. Biofilm dispersal in Xanthomonas campestris is controlled by cell–cell signaling and is required for full virulence to plants , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[10] U. Jenal,et al. Structural and mechanistic determinants of c-di-GMP signalling , 2009, Nature Reviews Microbiology.
[11] M. Vulić,et al. Ciprofloxacin Causes Persister Formation by Inducing the TisB toxin in Escherichia coli , 2010, PLoS biology.
[12] B. Wickes,et al. Inhibition of Candida albicans Biofilm Formation by Farnesol, a Quorum-Sensing Molecule , 2002, Applied and Environmental Microbiology.
[13] Matthew R. Parsek,et al. Pseudomonas aeruginosa Rugose Small-Colony Variants Have Adaptations That Likely Promote Persistence in the Cystic Fibrosis Lung , 2009, Journal of bacteriology.
[14] K. Hedlund,et al. Uropathogenic Escherichia coli Modulates Immune Responses and Its Curli Fimbriae Interact with the Antimicrobial Peptide LL-37 , 2010, PLoS pathogens.
[15] Alice Dohnalkova,et al. Electrically conductive bacterial nanowires produced by Shewanella oneidensis strain MR-1 and other microorganisms. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[16] D. Learn,et al. Hypochlorite scavenging by Pseudomonas aeruginosa alginate , 1987, Infection and immunity.
[17] Elizabeth M. Boon,et al. Nitric oxide regulation of cyclic di-GMP synthesis and hydrolysis in Shewanella woodyi. , 2012, Biochemistry.
[18] Michael Y. Galperin,et al. Cyclic di-GMP: the First 25 Years of a Universal Bacterial Second Messenger , 2013, Microbiology and Molecular Reviews.
[19] U. Römling,et al. Biofilm infections, their resilience to therapy and innovative treatment strategies , 2012, Journal of internal medicine.
[20] D. Sinclair,et al. Killing by Bactericidal Antibiotics Does Not Depend on Reactive Oxygen Species , 2022 .
[21] C. Armero,et al. Antimicrobial Resistance in More than 100,000 Escherichia coli Isolates According to Culture Site and Patient Age, Gender, and Location , 2011, Antimicrobial Agents and Chemotherapy.
[22] K. Sauer,et al. NO-Induced Biofilm Dispersion in Pseudomonas aeruginosa Is Mediated by an MHYT Domain-Coupled Phosphodiesterase , 2013, Journal of bacteriology.
[23] J. Lawrence,et al. Behavior ofPseudomonas fluorescens within the hydrodynamic boundary layers of surface microenvironments , 1987, Microbial Ecology.
[24] S. Kjelleberg,et al. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors , 2003, The EMBO journal.
[25] L. Lindbom,et al. Induction of the human cathelicidin LL‐37 as a novel treatment against bacterial infections , 2012, Journal of leukocyte biology.
[26] Zhijian J. Chen,et al. Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway , 2013, Science.
[27] D. Hassett,et al. Nitric Oxide Signaling in Pseudomonas aeruginosa Biofilms Mediates Phosphodiesterase Activity, Decreased Cyclic Di-GMP Levels, and Enhanced Dispersal , 2009, Journal of bacteriology.
[28] Karl-Peter Hopfner,et al. Structural biochemistry of a bacterial checkpoint protein reveals diadenylate cyclase activity regulated by DNA recombination intermediates. , 2008, Molecular cell.
[29] R. Dean,et al. Alginate inhibition of the uptake of Pseudomonas aeruginosa by macrophages. , 1988, Journal of general microbiology.
[30] M. Rohde,et al. The multicellular morphotypes of Salmonella typhimurium and Escherichia coli produce cellulose as the second component of the extracellular matrix , 2001, Molecular microbiology.
[31] Robert E W Hancock,et al. Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. , 2013, Current opinion in microbiology.
[32] J. Costerton,et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm. , 1998, Science.
[33] K. Marshall,et al. Selective sorption of bacteria from seawater. , 1971, Canadian journal of microbiology.
[34] Boris Hayete,et al. Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli , 2007 .
[35] D. Portnoy,et al. STING-Dependent Type I IFN Production Inhibits Cell-Mediated Immunity to Listeria monocytogenes , 2014, PLoS pathogens.
[36] J. Costerton,et al. Observations of fouling biofilm formation. , 1981, Canadian journal of microbiology.
[37] M. Hensel,et al. Biofilm formation by Salmonella enterica serovar Typhimurium colonizing solid tumours , 2011, Cellular microbiology.
[38] N. Rosenberg,et al. Periprosthetic Infection Following Total Knee Arthroplasty , 2013 .
[39] L. Pasteur. Mémoire sur la fermentation acétique , 1864 .
[40] Vincent T. Lee,et al. Systematic identification of conserved bacterial c-di-AMP receptor proteins , 2013, Proceedings of the National Academy of Sciences.
[41] Gordon Y C Cheung,et al. Phenol-soluble modulins--critical determinants of staphylococcal virulence. , 2014, FEMS microbiology reviews.
[42] N. Høiby,et al. Pseudomonas aeruginosa biofilms in cystic fibrosis. , 2010, Future microbiology.
[43] R. Frykberg,et al. Surgical management of diabetic foot infections and osteomyelitis. , 2007, Clinics in podiatric medicine and surgery.
[44] E. Nudler,et al. H2S: A Universal Defense Against Antibiotics in Bacteria , 2011, Science.
[45] Antoni van Leeuwenhoek,et al. Antony Van Leeuwenhoek and His 'Little Animals' , 1932, The Indian Medical Gazette.
[46] S. Hultgren,et al. Intracellular Bacterial Biofilm-Like Pods in Urinary Tract Infections , 2003, Science.
[47] P. Kolenbrander,et al. Lactose-reversible coaggregation between oral actinomycetes and Streptococcus sanguis , 1981, Infection and immunity.
[48] R. Kolter,et al. Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili , 1998, Molecular microbiology.
[49] J. Costerton,et al. Pseudomonas aeruginosa Displays Multiple Phenotypes during Development as a Biofilm , 2002, Journal of bacteriology.
[50] A. Camilli,et al. Cyclic diguanylate (c‐di‐GMP) regulates Vibrio cholerae biofilm formation , 2004, Molecular microbiology.
[51] S. Dowd,et al. Chronic wounds and the medical biofilm paradigm. , 2010, Journal of wound care.
[52] J. Imlay,et al. High Levels of Intracellular Cysteine Promote Oxidative DNA Damage by Driving the Fenton Reaction , 2003, Journal of bacteriology.
[53] G. O’Toole,et al. The developmental model of microbial biofilms: ten years of a paradigm up for review. , 2009, Trends in microbiology.
[54] Marcus J Schultz,et al. Biomaterial-Associated Infection: Locating the Finish Line in the Race for the Surface , 2012, Science Translational Medicine.
[55] D. Amikam,et al. Elevated expression of the CD4 receptor and cell cycle arrest are induced in Jurkat cells by treatment with the novel cyclic dinucleotide 3′,5′‐cyclic diguanylic acid , 1999, FEBS letters.
[56] S. Molin,et al. Development and Dynamics of Pseudomonassp. Biofilms , 2000, Journal of bacteriology.
[57] N. Høiby,et al. Targeting quorum sensing in Pseudomonas aeruginosa biofilms: current and emerging inhibitors. , 2013, Future microbiology.
[58] Jeremy S. Webb,et al. Nitric oxide‐mediated dispersal in single‐ and multi‐species biofilms of clinically and industrially relevant microorganisms , 2009, Microbial biotechnology.
[59] U. Römling,et al. GGDEF and EAL domains inversely regulate cyclic di‐GMP levels and transition from sessility to motility , 2004, Molecular microbiology.
[60] K. Lewis. Platforms for antibiotic discovery , 2013, Nature Reviews Drug Discovery.
[61] H. Stiver,et al. Inhibition of polymorphonuclear leukocyte chemotaxis by the mucoid exopolysaccharide of Pseudomonas aeruginosa. , 1988, Clinical and investigative medicine. Medecine clinique et experimentale.
[62] Ralph Mitchell,et al. Mechanism of the Initial Events in the Sorption of Marine Bacteria to Surfaces , 1970 .
[63] S. Bezrukov,et al. Persister‐promoting bacterial toxin TisB produces anion‐selective pores in planar lipid bilayers , 2012, FEBS letters.
[64] W. Zimmerli,et al. Diagnosis of Periprosthetic Joint Infections in Clinical Practice , 2012, The International journal of artificial organs.
[65] K. Lewis,et al. Specialized Persister Cells and the Mechanism of Multidrug Tolerance in Escherichia coli , 2004, Journal of bacteriology.
[66] N. Høiby,et al. A personal history of research on microbial biofilms and biofilm infections. , 2014, Pathogens and disease.
[67] S. Rice,et al. Nitric oxide: a key mediator of biofilm dispersal with applications in infectious diseases. , 2014, Current pharmaceutical design.
[68] U. Römling,et al. Control of pathogen growth and biofilm formation using a urinary catheter that releases antimicrobial nitrogen oxides. , 2013, Free radical biology & medicine.
[69] J. Collins,et al. Mistranslation of Membrane Proteins and Two-Component System Activation Trigger Antibiotic-Mediated Cell Death , 2008, Cell.
[70] A. Hanssen,et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[71] M. Rohde,et al. Pseudomonas aeruginosa cupA-encoded fimbriae expression is regulated by a GGDEF and EAL domain-dependent modulation of the intracellular level of cyclic diguanylate. , 2007, Environmental microbiology.
[72] W. Zimmerli,et al. Clinical presentation and treatment of orthopaedic implant‐associated infection , 2014, Journal of internal medicine.
[73] J. Nickel,et al. Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material , 1985, Antimicrobial Agents and Chemotherapy.
[74] V. Korolik,et al. Inhibition of Bacterial Biofilm Formation and Swarming Motility by a Small Synthetic Cationic Peptide , 2012, Antimicrobial Agents and Chemotherapy.
[75] Thomas Bjarnsholt,et al. Towards diagnostic guidelines for biofilm-associated infections. , 2012, FEMS immunology and medical microbiology.
[76] B. Ersbøll,et al. Quantification of biofilm structures by the novel computer program COMSTAT. , 2000, Microbiology.
[77] D. Stickler,et al. Bacterial biofilms in patients with indwelling urinary catheters , 2008, Nature Clinical Practice Urology.
[78] D. Hassett,et al. Involvement of Nitric Oxide in Biofilm Dispersal of Pseudomonas aeruginosa , 2006, Journal of bacteriology.
[79] M. Rohde,et al. Murine solid tumours as a novel model to study bacterial biofilm formation in vivo , 2014, Journal of internal medicine.
[80] H. Sondermann,et al. Sensing the messenger: The diverse ways that bacteria signal through c‐di‐GMP , 2012, Protein science : a publication of the Protein Society.
[81] N. Høiby. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey. , 1977, Acta pathologica et microbiologica Scandinavica. Supplement.
[82] J. H. Boom,et al. Regulation of cellulose synthesis in Acetobacter xylinum by cyclic diguanylic acid , 1987, Nature.
[83] C. Guzmán,et al. Cyclic di‐nucleotides: new era for small molecules as adjuvants , 2012, Microbial biotechnology.
[84] Richard D. Smith,et al. Activated ClpP kills persisters and eradicates a chronic biofilm infection , 2013, Nature.
[85] Gordon Y C Cheung,et al. Staphylococcus epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilm-associated infection in mice. , 2011, The Journal of clinical investigation.
[86] Michael Y. Galperin,et al. New metrics for comparative genomics. , 2006, Current opinion in biotechnology.
[87] J. Helmann,et al. Analysis of the role of Bacillus subtilis σM in β‐lactam resistance reveals an essential role for c‐di‐AMP in peptidoglycan homeostasis , 2012, Molecular microbiology.
[88] N. Høiby. Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response. , 2009 .
[89] K. Gerdes,et al. RETRACTED: (p)ppGpp Controls Bacterial Persistence by Stochastic Induction of Toxin-Antitoxin Activity , 2013, Cell.
[90] F. Yildiz,et al. Role of Vibrio polysaccharide (vps) genes in VPS production, biofilm formation and Vibrio cholerae pathogenesis , 2010, Microbiology.
[91] Paul Stoodley,et al. Bacterial biofilms: from the Natural environment to infectious diseases , 2004, Nature Reviews Microbiology.
[92] J W Costerton,et al. How bacteria stick. , 1978, Scientific American.
[93] M. Hentzer,et al. Dynamics and Spatial Distribution of β-Lactamase Expression in Pseudomonas aeruginosa Biofilms , 2004, Antimicrobial Agents and Chemotherapy.
[94] E. Wagner,et al. Two antisense RNAs target the transcriptional regulator CsgD to inhibit curli synthesis , 2010, The EMBO journal.
[95] A. Henrici. Studies of Freshwater Bacteria , 1933, Journal of bacteriology.
[96] J. Mattick,et al. Extracellular DNA required for bacterial biofilm formation. , 2002, Science.
[97] K. Lewis,et al. Persister cells. , 2010, Annual review of microbiology.
[98] G L Kenyon,et al. Structural identification of autoinducer of Photobacterium fischeri luciferase. , 1981, Biochemistry.
[99] Kshitij D Modi,et al. Noninvasive Biophotonic Imaging for Monitoring of Catheter-Associated Urinary Tract Infections and Therapy in Mice , 2005, Infection and Immunity.
[100] E. O’Shea,et al. A serine sensor for multicellularity in a bacterium , 2013, eLife.
[101] H. Vlamakis,et al. Sticking together: building a biofilm the Bacillus subtilis way , 2013, Nature Reviews Microbiology.
[102] J. Mekalanos,et al. Cyclic Dinucleotides and the Innate Immune Response , 2013, Cell.
[103] D. Mack,et al. Molecular basis of intercellular adhesion in the biofilm‐forming Staphylococcus epidermidis , 1996, Molecular microbiology.
[104] B. Giese,et al. Cell cycle-dependent dynamic localization of a bacterial response regulator with a novel di-guanylate cyclase output domain. , 2004, Genes & development.
[105] H. Sahl,et al. Dysregulation of bacterial proteolytic machinery by a new class of antibiotics , 2005, Nature Medicine.
[106] R. Breaker,et al. Riboswitches in eubacteria sense the second messenger c-di-AMP , 2013, Nature chemical biology.
[107] Anders Folkesson,et al. Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective , 2012, Nature Reviews Microbiology.
[108] M. Parsek,et al. Bacterial biofilms: an emerging link to disease pathogenesis. , 2003, Annual review of microbiology.
[109] R. Vance,et al. The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING. , 2013, Cell reports.
[110] W. Sierralta,et al. Multicellular and aggregative behaviour of Salmonella typhimurium strains is controlled by mutations in the agfD promoter , 1998, Molecular microbiology.
[111] S. Kjelleberg,et al. Cell Death in Pseudomonas aeruginosa Biofilm Development , 2003, Journal of bacteriology.
[112] M J Bissell,et al. How does the extracellular matrix direct gene expression? , 1982, Journal of theoretical biology.
[113] A. Oliver,et al. ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[114] J. Collins,et al. A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics , 2007, Cell.
[115] F. Yildiz,et al. Structural Characterization of the Extracellular Polysaccharide from Vibrio cholerae O1 El-Tor , 2014, PloS one.
[116] A. Hirschberg,et al. Estrogen Supports Urothelial Defense Mechanisms , 2013, Science Translational Medicine.
[117] T. Lithgow,et al. MrkH, a Novel c-di-GMP-Dependent Transcriptional Activator, Controls Klebsiella pneumoniae Biofilm Formation by Regulating Type 3 Fimbriae Expression , 2011, PLoS pathogens.
[118] A. Mitchell,et al. Critical Role of Bcr1-Dependent Adhesins in C. albicans Biofilm Formation In Vitro and In Vivo , 2006, PLoS pathogens.
[119] Michael Y. Galperin,et al. Diversity of structure and function of response regulator output domains. , 2010, Current opinion in microbiology.
[120] M. Chapman,et al. Promiscuous Cross-seeding between Bacterial Amyloids Promotes Interspecies Biofilms* , 2012, The Journal of Biological Chemistry.
[121] P. Larock,et al. An extraterrestrial habitat on earth: The algal mat of Don Jaun Pond , 1983 .
[122] T. Wood,et al. Inhibition of biofilm formation and swarming of Bacillus subtilis by (5Z)‐4‐bromo‐5‐(bromomethylene)‐3‐butyl‐2(5H)‐furanone , 2002, Letters in applied microbiology.
[123] Fitnat H. Yildiz,et al. Molecular Architecture and Assembly Principles of Vibrio cholerae Biofilms , 2012, Science.
[124] Roger E. Bumgarner,et al. Gene expression in Pseudomonas aeruginosa biofilms , 2001, Nature.
[125] J. Costerton,et al. Bacterial biofilms: a common cause of persistent infections. , 1999, Science.
[126] C. E. Zobell,et al. The Significance of Marine Bacteria in the Fouling of Submerged Surfaces , 1935, Journal of bacteriology.
[127] Roberto Kolter,et al. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis , 1998, Molecular microbiology.
[128] R. Hancock,et al. Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation , 2008, Infection and Immunity.
[129] H. Lilie,et al. The antibiotic ADEP reprogrammes ClpP, switching it from a regulated to an uncontrolled protease , 2009, EMBO molecular medicine.
[130] N. Zenkin,et al. Molecular mechanism of bacterial persistence by HipA. , 2013, Molecular cell.
[131] K. Nealson,et al. Shewanella oneidensis MR-1 chemotaxis proteins and electron-transport chain components essential for congregation near insoluble electron acceptors. , 2012, Biochemical Society transactions.
[132] Timothy K Lu,et al. Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy , 2009, Proceedings of the National Academy of Sciences.
[133] Yasuhiko Irie,et al. Self-produced exopolysaccharide is a signal that stimulates biofilm formation in Pseudomonas aeruginosa , 2012, Proceedings of the National Academy of Sciences.
[134] D. Lebeaux,et al. A Rat Model of Central Venous Catheter to Study Establishment of Long-Term Bacterial Biofilm and Related Acute and Chronic Infections , 2012, PloS one.
[135] Leo Eberl,et al. Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. , 2002, Microbiology.
[136] James J. Collins,et al. Metabolite-Enabled Eradication of Bacterial Persisters by Aminoglycosides , 2011, Nature.
[137] Philip S. Stewart,et al. Contributions of Antibiotic Penetration, Oxygen Limitation, and Low Metabolic Activity to Tolerance of Pseudomonas aeruginosa Biofilms to Ciprofloxacin and Tobramycin , 2003, Antimicrobial Agents and Chemotherapy.
[138] K. Gerdes,et al. Bacterial persistence by RNA endonucleases , 2011, Proceedings of the National Academy of Sciences.
[139] A. Mitchell,et al. Genetic control of Candida albicans biofilm development , 2011, Nature Reviews Microbiology.
[140] D. Otzen,et al. Expression of Fap amyloids in Pseudomonas aeruginosa, P. fluorescens, and P. putida results in aggregation and increased biofilm formation , 2013, MicrobiologyOpen.
[141] D. Lebeaux,et al. From in vitro to in vivo Models of Bacterial Biofilm-Related Infections , 2013, Pathogens.
[142] A. Spiers,et al. Genes encoding a cellulosic polymer contribute toward the ecological success of Pseudomonas fluorescens SBW25 on plant surfaces , 2003, Molecular ecology.
[143] R. Kolter,et al. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development , 1998, Molecular microbiology.
[144] M. Chapman,et al. Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation. , 2009, Nature chemical biology.
[145] Tami D. Lieberman,et al. Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection. , 2012, The Journal of infectious diseases.